HEALTHBANK HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.104 SGD | +23.81% |
|
-.--% | -27.78% |
| 26/02 | HealthBank Holdings’ Attributable Loss for H2 2023 Widens; Revenue Plummets 92% | MT |
| 23/02 | HealthBank Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 43.97 | 55.68 | 41.8 | 32.64 | 69.46 | 69.69 |
| Enterprise Value (EV) 1 | -17.54 | 45.97 | 40.58 | 33.81 | 66.72 | 68.66 |
| P/E ratio | -19.1 x | -3.58 x | -8.52 x | -8.96 x | -5.4 x | -1.93 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 4.29 x | 13.8 x | - | 330 x | 183 x | 308 x |
| EV / Revenue | -1.71 x | 11.4 x | - | 342 x | 176 x | 304 x |
| EV / EBITDA | 4.88 x | -5.95 x | -2.52 x | -8.97 x | -18.5 x | -27.7 x |
| EV / FCF | -0.31 x | 5.12 x | -2.24 x | 5.09 x | -6.34 x | 8.97 x |
| FCF Yield | -322% | 19.5% | -44.6% | 19.6% | -15.8% | 11.1% |
| Price to Book | 0.56 x | 0.89 x | 0.64 x | 0.52 x | 1.16 x | 2.85 x |
| Nbr of stocks (in thousands) | 78,000 | 78,000 | 78,000 | 78,000 | 94,300 | 94,300 |
| Reference price 2 | 0.5637 | 0.7139 | 0.5359 | 0.4184 | 0.7366 | 0.7390 |
| Announcement Date | 11/04/19 | 15/04/20 | 12/04/21 | 12/04/22 | 13/04/23 | 10/04/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 10.24 | 4.043 | - | 0.099 | 0.379 | 0.226 |
| EBITDA 1 | -3.597 | -7.726 | -16.11 | -3.768 | -3.616 | -2.476 |
| EBIT 1 | -4.147 | -8.795 | -16.86 | -3.772 | -3.62 | -2.479 |
| Operating Margin | -40.49% | -217.54% | - | -3,810.1% | -955.15% | -1,096.9% |
| Earnings before Tax (EBT) 1 | -1.28 | -21.12 | 3.695 | -3.857 | -11.18 | -36.08 |
| Net income 1 | -2.299 | -15.57 | -4.907 | -3.643 | -11.13 | -36.02 |
| Net margin | -22.45% | -385.13% | - | -3,679.8% | -2,936.94% | -15,938.94% |
| EPS 2 | -0.0295 | -0.1996 | -0.0629 | -0.0467 | -0.1365 | -0.3820 |
| Free Cash Flow 1 | 56.52 | 8.98 | -18.11 | 6.641 | -10.52 | 7.65 |
| FCF margin | 551.9% | 222.12% | - | 6,708.46% | -2,775.33% | 3,384.96% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 11/04/19 | 15/04/20 | 12/04/21 | 12/04/22 | 13/04/23 | 10/04/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 1.18 | - | - |
| Net Cash position 1 | 61.5 | 9.72 | 1.23 | - | 2.74 | 1.04 |
| Leverage (Debt/EBITDA) | - | - | - | -0.3121 x | - | - |
| Free Cash Flow 1 | 56.5 | 8.98 | -18.1 | 6.64 | -10.5 | 7.65 |
| ROE (net income / shareholders' equity) | -1.61% | -24.2% | 4.9% | -5.78% | -18.2% | -85.4% |
| ROA (Net income/ Total Assets) | -2.75% | -5.65% | -13.2% | -3.27% | -3.37% | -3.57% |
| Assets 1 | 83.51 | 275.8 | 37.11 | 111.4 | 330.6 | 1,009 |
| Book Value Per Share 2 | 1.000 | 0.8000 | 0.8300 | 0.8100 | 0.6400 | 0.2600 |
| Cash Flow per Share 2 | 0.0300 | 0.1200 | 0.0200 | 0.1000 | 0.0300 | 0.0100 |
| Capex 1 | 0.28 | 0.03 | - | 0.03 | - | - |
| Capex / Sales | 2.69% | 0.69% | - | 31.31% | - | - |
| Announcement Date | 11/04/19 | 15/04/20 | 12/04/21 | 12/04/22 | 13/04/23 | 10/04/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -27.78% | 7.23M | |
| +4.36% | 67.22B | |
| +10.05% | 50.11B | |
| +10.41% | 15.99B | |
| +13.35% | 14.95B | |
| +17.75% | 11.03B | |
| +25.63% | 9.61B | |
| +10.17% | 4.99B | |
| +8.01% | 4.55B | |
| +21.35% | 3.74B |
- Stock Market
- Equities
- 40B Stock
- Financials HealthBank Holdings Limited